News
News
News
16 May 2023
Azelis strengthens its footprint in life sciences with the acquisition of Gillco Ingredients in the USA
News
2 March 2023
FY2022 results: Strong momentum drives 70% growth in adjusted EBITA
Frank Bergonzi, CEO and President, Azelis Americas Interviewed for Chemical Week Cover Story News29 October 2018Frank Bergonzi, CEO and President, Azelis Americas Interviewed for Chemical Week Cover Story
EcoVadis Gold rating for Azelis' CSR performance News12 September 2018EcoVadis Gold rating for Azelis' CSR performance
Funds advised by Apax Partners receive binding offer for Azelis News19 June 2018Funds advised by Apax Partners receive binding offer for Azelis
Azelis opens a new pharmaceutical manufacturing facility in Sankt Augustin, Germany News12 June 2018Azelis opens a new pharmaceutical manufacturing facility in Sankt Augustin, Germany
Frank Bergonzi, Azelis CEO and President, Americas wins Academy of Distinguished Engineers Award from University of Connecticut News30 April 2018Frank Bergonzi, Azelis CEO and President, Americas wins Academy of Distinguished Engineers Award from University of Connecticut
Azelis launches company-wide Corporate Social Responsibility (CSR) programme News25 April 2018Azelis launches company-wide Corporate Social Responsibility (CSR) programme
Azelis hires Al Pearce to join the leadership team in the Americas. Press8 January 2018Azelis hires Al Pearce to join the leadership team in the Americas.
Azelis gains a leading position in Australia and New Zealand with the acquisition of Chemcolour News25 July 2017Azelis gains a leading position in Australia and New Zealand with the acquisition of Chemcolour
Azelis wins another award for product innovation News7 June 2017Azelis wins another award for product innovation
Azelis enters into important distribution agreement with Novo Nordisk Pharmatech News25 May 2017Azelis enters into important distribution agreement with Novo Nordisk Pharmatech